These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus. Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M. Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961 [Abstract] [Full Text] [Related]
27. [Characteristics of the cytokine profile and peripheral blood lymphocyte subpopulations in patients with chronic viral hepatitis B and C in comparison to severity of morphological changes of the liver]. Lazareva AS, Volchkova EV, Umbetova KT, Chulanov VP, Parkhomenko IuG, Kiselevskiĭ MV, Pak SG. Ter Arkh; 2009 Aug; 81(4):55-60. PubMed ID: 19514423 [Abstract] [Full Text] [Related]
31. Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection. Ciesek S, Liermann H, Hadem J, Greten T, Tillmann HL, Cornberg M, Aslan N, Manns MP, Wedemeyer H. J Viral Hepat; 2008 Mar; 15(3):200-11. PubMed ID: 18233993 [Abstract] [Full Text] [Related]
32. Long-term efficacy of human papillomavirus vaccination. Ault KA. Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S27-30. PubMed ID: 17938016 [Abstract] [Full Text] [Related]
33. Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients. Schlaphoff V, Klade CS, Jilma B, Jelovcan SB, Cornberg M, Tauber E, Manns MP, Wedemeyer H, IC41 Study Group. Vaccine; 2007 Sep 17; 25(37-38):6793-806. PubMed ID: 17686555 [Abstract] [Full Text] [Related]
34. [Vaccinations in sports and recommendations for immunization against flu, hepatitis A and hepatitis B]. Constantini N, Ken-Dror A, Eliakim A, Galatzkia L, Morag A, Mann G, Volach B, Asharov J, Shoval D. Harefuah; 2001 Dec 17; 140(12):1191-5, 1228. PubMed ID: 11789307 [Abstract] [Full Text] [Related]
35. Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy. Yutani S, Yamada A, Yoshida K, Takao Y, Tamura M, Komatsu N, Ide T, Tanaka M, Sata M, Itoh K. Vaccine; 2007 Oct 16; 25(42):7429-35. PubMed ID: 17845828 [Abstract] [Full Text] [Related]
37. [Should we vaccinate patients with systemic lupus]. Wiesik-Szewczyk E, Lacki JK, Chwalińiska-Sadowska H. Pol Merkur Lekarski; 2007 Nov 16; 23(137):395-8. PubMed ID: 18361328 [Abstract] [Full Text] [Related]